TAM
NBIX icon

Tealwood Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Tealwood Asset Management’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.85M Sell
10,955
-68
-0.6% -$10.1K 0.71% 64
2026
Q1 		$1.45M Sell
11,023
-64
-0.6% -$8.49K 0.66% 83
2025
Q4 		$1.57M Sell
11,087
-284
-2% -$41.1K 0.71% 74
2025
Q3 		$1.6M Sell
11,371
-339
-3% -$45.9K 0.65% 77
2025
Q2 		$1.47M Sell
11,710
-14
-0.1% -$1.61K 0.66% 75
2025
Q1 		$1.3M Sell
11,724
-187
-2% -$23.7K 0.6% 82
2024
Q4 		$1.63M Buy
11,911
+118
+1% +$14.6K 0.67% 68
2024
Q3 		$1.36M Sell
11,793
-106
-0.9% -$14.5K 0.6% 84
2024
Q2 		$1.64M Sell
11,899
-109
-0.9% -$14.9K 0.99% 43
2024
Q1 		$1.66M Sell
12,008
-247
-2% -$33.7K 0.75% 59
2023
Q4 		$1.61M Sell
12,255
-219
-2% -$25.2K 0.77% 54
2023
Q3 		$1.4M Sell
12,474
-361
-3% -$38K 0.72% 60
2023
Q2 		$1.21M Sell
12,835
-219
-2% -$21.4K 0.59% 87
2023
Q1 		$1.32M Buy
13,054
+29
+0.2% +$3.02K 0.67% 65
2022
Q4 		$1.56M Sell
13,025
-1,146
-8% -$134K 0.81% 46
2022
Q3 		$1.5M Sell
14,171
-23
-0.2% -$2.33K 0.81% 44
2022
Q2 		$1.38M Sell
14,194
-402
-3% -$37.1K 0.69% 54
2022
Q1 		$1.37M Buy
14,596
+9,399
+181% +$797K 0.58% 77
2021
Q4 		$443K Sell
5,197
-7,034
-58% -$647K 0.18% 122
2021
Q3 		$1.17M Buy
+12,231
New +$1.16M 0.47% 109
2021
Q1 		$1.25M Buy
12,799
+646
+5% +$67.7K 0.5% 103
2020
Q4 		$1.17M Buy
12,153
+6,131
+102% +$592K 0.55% 92
2020
Q3 		$579K Buy
+6,022
New +$697K 0.38% 80

Other funds holding NBIX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PBBUPS
PKO BP Bankowy Universal Pension Society Warsaw, Poland $350M AUM 272.18% 1-Year Est. Return
AS
Aware Super Sydney, Australia $7.06B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Tealwood Asset Management's NBIX Position: Q2 2026 in Review

Tealwood Asset Management reduced its Neurocrine Biosciences (NBIX) stake by 0.62% in Q2 2026, selling an estimated $10.1K and leaving 10,955 shares worth $1.85M. The position accounts for 0.71% of the portfolio, ranked #64.

Tealwood Asset Management first reported a position in NBIX in Q3 2020 and has held it in 23 quarters since. 260 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Tealwood Asset Management held 10,955 shares of Neurocrine Biosciences worth $1.85M as of Q2 2026.
  • Tealwood Asset Management sold 68 Neurocrine Biosciences shares in Q2 2026, an estimated $10.1K.
  • Neurocrine Biosciences made up 0.71% of Tealwood Asset Management's portfolio in Q2 2026, its #64 holding.
  • Tealwood Asset Management first reported a position in Neurocrine Biosciences in Q3 2020 and has held it in 23 quarters since.
  • 260 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Tealwood Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.